Eli Lilly’s obesity drug shows up to 30% weight loss in trial

Eli Lilly's new obesity drug retatrutide shows remarkable results. In a major trial, patients lost up to 30% of their body weight. This once-weekly injection targets multiple hormone receptors. The drug also improved heart health markers. Experts believe retatrutide could be a game-changer for treating obesity and improving patient health.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/FJEq4Sa
via IFTTT

Read More

No cosmetic job with jabs, warns drug regulator CDSCO

The notice issued by the Central Drugs Standard Control Organisation (CDSCO) cites provisions of the Drugs and Cosmetics Act, 1940, and the Cosmetics Rules, 2020.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/QKycW0G
via IFTTT

Read More

India plans national registry to track implantable medical devices and patients

India is set to launch a national registry for implantable medical devices. This initiative aims to track all devices and patients, ensuring only certified products are used. The registry will help curb overuse and fix accountability. It will also aid in identifying patients during recalls and tracking real-world safety.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/hDYFcAn
via IFTTT

Read More

Chemists’ strike: CDSCO moves to prevent shortages

The CDSCO has advised state drug controllers to prevent drug scarcity during the AIOCD's proposed e-pharmacy strike on May 20. Measures include ensuring pharmacies remain open, coordinating with police, and negotiating to keep some shops operational to avoid medicine deserts. The government emphasizes uninterrupted public access to medicines as a top priority.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/uMGf1Jj
via IFTTT

Read More

NCLAT allows Lyka Labs appeal; asks Modi Lifecare to pay Rs 63 lakh or face insolvency proceedings

The NCLAT has ruled in favor of Lyka Labs. It overturned a previous NCLT decision. Modi Lifecare Industries must now pay Rs 63 lakh within 30 days. Failure to pay will lead to insolvency proceedings against the company. The tribunal found that Modi Lifecare acknowledged its debt. This ruling stems from unpaid royalties under a technical guidance agreement.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/xt5aeV0
via IFTTT

Read More

Hearzap to acquire Amplifon India, expand network to 420 hearing care centres

Hearzap is acquiring Amplifon India in a deal that will significantly expand the company's presence across the country. The combined entity will operate approximately 420 hearing care centers. With this move, Hearzap is seeking to strengthen position in the organised hearing care market.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/XzVcGMp
via IFTTT

Read More

Rising input costs, export slump take a toll on drug companies' health

India's drug makers are facing a double blow. A weaker rupee makes imported raw materials more expensive. Global economic worries are also slowing down demand for Indian medicines abroad. This is squeezing profits for manufacturers. Companies are trying to focus on more profitable products. The situation presents a tough operating environment for the industry.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/UQdLPIH
via IFTTT

Read More